1st Quarter - Report
ALPINE GROUP PARTNERS, LLC. for EMERGENT BIOSOLUTIONS
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.749, the Lower Drug Costs through Competition Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| COURTNEY JOHNSON | Research Assistant, House Energy & Commerce Committee |
| LAWRENCE SPIVEY | Professional Staff, Senate Appropriations Committee |
Budget/Appropriations BUD
FY 2017 and FY 2018 Appropriations - provisions related to development, acquisition and stockpiling of medical countermeasures. Provisions related to development, acquisition and stockpiling of medical countermeasures for the US Government.
| Lobbyist | Covered position, as disclosed |
|---|---|
| COURTNEY JOHNSON | Research Assistant, House Energy & Commerce Committee |
| LAWRENCE SPIVEY | Professional Staff, Senate Appropriations Committee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.